Burn Care Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Burn Care Market Report is Segmented by Product Type (Advanced Dressings, Traditional Dressings, Biologics, Therapy Devices, and More), Depth of Burn (Minor Burns, Partial-Thickness Burns, Full-Thickness Burns), End User (Hospitals & Clinics, Specialised Burn Centres, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Burn Care Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Burn Care Market with other markets in Healthcare Industry

Burn Care Market Analysis by Mordor Intelligence

The Burn Care Market size is estimated at USD 2.88 billion in 2025, and is expected to reach USD 3.96 billion by 2030, at a CAGR of 6.56% during the forecast period (2025-2030).

Severe weather events, electric-vehicle battery fires, and industrial accidents continue to elevate the global incidence of burn injuries, sustaining demand for advanced dressings, biologics, and portable negative-pressure therapy systems. Reimbursement reforms in the United States, Europe, and selected Asia-Pacific economies support wider adoption of sophisticated wound technologies. Meanwhile, ambient-intelligence tools such as smart bandages and bioelectronic monitors shorten healing times and reduce readmissions, driving hospital cost-containment strategies. Strategic investments from public research programs and military agencies accelerate translation of laboratory breakthroughs into commercial products.

Key Report Takeaways

  • By product type, advanced dressings led with 52.87% burn care market share in 2024, while biologics recorded the fastest 9.83% CAGR through 2030. 
  • By depth of burn, partial-thickness cases accounted for 43.94% of the burn care market size in 2024, whereas full-thickness burns are projected to expand at an 8.73% CAGR. 
  • By end user, hospitals and clinics held 59.92% revenue in 2024; ambulatory surgery centers are forecast to grow 10.19% annually to 2030. 
  • By geography, North America dominated with 39.74% of 2024 sales, and Asia-Pacific is expected to grow at an 8.16% CAGR through 2030.

Segment Analysis

By Product Type: Advanced Dressings Retain Leadership Amid Biologic Surge

Advanced dressings held 52.87% market share, of the burn care market in 2024. Iterative upgrades in hydrofiber foams, antimicrobial silver layers, and moisture-handling backings maintain clinician confidence and secure reimbursement. Smith+Nephew expanded its foam line in 2024, reinforcing stickiness within hospital formularies. Traditional dressings persist in budget-sensitive outpatient settings, sustaining baseline demand. Therapy devices, notably portable NPWT units, speed patient discharge and bolster outpatient revenue models. Topical antimicrobial gels remain standard prophylaxis for minor wounds.

Biologics, while smaller in absolute value, recorded 9.83% CAGR from 2025 to 2030, the highest across product categories. FDA clearance of AVITA Medical’s Cohealyx dermal matrix in December 2024 widens indications and triples the firm’s total addressable population. Bioengineered skin delivers outcomes similar to autografting without donor-site morbidity. However, the burn care market size for biologics stays curtailed by high manufacturing cost and complex cold-chain logistics. As payers refine coverage criteria, vendors that generate robust comparative-effectiveness data will gain share.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Depth of Burn: Prevalence of Partial-Thickness Dominates as Full-Thickness Gains Momentum

Partial-thickness injuries comprised 43.94% of the burn care market in 2024, benefiting from established moist-healing protocols and outpatient care pathways. Patients typically receive hydrogel or silicone dressings that minimize trauma on changes, reducing infection risk and scarring. Minor wounds, often treated at home or in urgent-care settings, drive demand for accessible dressings and analgesic sprays. Clinician familiarity, predictable healing times, and lower material cost sustain steady revenue.

Full-thickness burns, although fewer in case volume, will rise at an 8.73% CAGR to 2030. The January 2025 Los Angeles fires exposed tens of thousands of residents, highlighting the need for highly specialized reconstruction. Advanced dermal matrices from Integra anchor staged reconstruction algorithms that now achieve higher survival rates. Growth accelerates as critical-care capabilities improve outside traditional burn centers, expanding geographical availability of complex surgeries. The burn care market size for these severe presentations therefore shows disproportionate revenue contribution compared with case count.

By End User: Hospitals Dominate While Ambulatory Centers Expand

Hospitals and clinics accounted for 59.92% of 2024 revenue in the burn care market. Level I burn centers integrate intensive care, surgical suites, and rehabilitation teams to manage complex trauma. The USD 650 million Military Burn Research Program funds innovations such as deployable resuscitation units, reinforcing hospital capabilities. Emergency departments also function as gatekeepers, initiating NPWT or graft placement before step-down to outpatient settings.

Ambulatory surgery centers are expected to register a 10.19% CAGR through 2030 as portable NPWT and advanced dressings enable same-day procedures. Smart bandages like iCares permit real-time monitoring outside hospital walls, giving clinicians confidence to shorten inpatient stays. Reimbursement incentives for site-of-service shifts, together with patient preference for home recovery, support ambulatory adoption. Vendors tailoring packaging and staff training for outpatient workflows will capture incremental opportunities in the burn care market.

Burn Care Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America held 39.74% of global revenue in 2024. Federal investments, including the USD 650 million Military Burn Research allocation, promote basic and translational science. CMS updates on skin-substitute coverage effective April 2025 further incentivize technology uptake. The Los Angeles wildfires exposed 41,000 people and demonstrated the region’s vulnerability. Canadian wildfires affected 2.7 million hectares and sent smoke toward 117 million Americans, indicating cross-border healthcare contingencies.

Europe combines strict regulatory oversight with rising wildfire activity around the Mediterranean. Healthcare systems focus on cost-effectiveness, prompting hospitals to adopt dressings that reduce total hospitalization days. Joint EU research programs foster collaboration between academic groups and device makers, accelerating approvals of smart hydrogel dressings.

Asia-Pacific is projected to achieve an 8.16% CAGR to 2030. Policymakers prioritize universal health coverage and invest in trauma infrastructure, creating strong tailwinds in the burn care market. A region-wide consensus issued new burn-assessment guidelines and emphasized workforce training. Private-equity interest grows as healthcare providers consolidate and seek digital-health partnerships.

Middle East & Africa and South America remain nascent yet show steady uptake of portable NPWT and silver dressings. Governments modernize emergency services to meet climate-related disaster demands. Multilateral aid and public-private collaborations introduce telehealth solutions for remote burn triage, gradually expanding the burn care market footprint in underserved regions.

Burn Care Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The competitive arena features diversified multinationals and agile biotech entrants. Smith+Nephew generated USD 5.5 billion sales in 2023 and leverages scale to bundle foams, infection-control products, and surgical tools. 3M separated its healthcare assets into Solventum, inheriting USD 340 million in federal contracts for NPWT systems. Integra LifeSciences anchors its USD 1.6 billion regenerative portfolio with AI-enabled wound analytics that guide graft decisions.

Disruptors target niche opportunities. Caltech’s iCares smart bandage integrates sensors and predictive algorithms, offering hospitals a data-rich alternative to conventional dressings. Start-ups in 3-D bioprinting supply custom scaffolds for full-thickness reconstructions. Patent filings on conductive hydrogels and polymer nanofibers accelerate as firms seek defensible IP. Heightened DOJ action over false claims raises compliance costs, favouring players with robust governance.

Strategic moves include partnerships with telehealth providers to track outpatients, licensing of antimicrobial coatings, and regional acquisitions that add distribution scale. Vendors also explore value-based contracts where reimbursement ties to documented healing outcomes, aligning incentives with payers and accountable-care organizations in the burn care industry.

Burn Care Industry Leaders

  1. Johnson & Johnson

  2. Mölnlycke Health Care AB

  3. 3M Company

  4. Smith & Nephew plc

  5. Cardinal Health Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Burn Care.jpg
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • April 2025: Caltech researchers launched the iCares smart bandage system capable of real-time wound monitoring and machine-learning-driven healing predictions, with clinical trials in 20 human patients demonstrating expert-level accuracy in predicting healing outcomes. The breakthrough technology received support from multiple health and research organizations and findings were published in Science Translational Medicine.
  • April 2025: The Centers for Medicare & Medicaid Services implemented comprehensive updates for skin substitutes effective April 13, 2025, expanding application limits and introducing new documentation requirements while reclassifying these products as 'wound care management products' to streamline coding and payment under the Physician Fee Schedule.
  • April 2025: The 2025 Military Burn Research Program allocated USD 650 million through the Congressionally Directed Medical Research Program, focusing on prevention, triage, and treatment innovations for austere environments with funding opportunities ranging from USD 200,000 to USD 1.7 million.
  • January 2025: ConvaTec welcomed the postponement of Local Coverage Determinations on skin substitutes in the United States, potentially impacting the availability and reimbursement of these products in the burn care market.

Table of Contents for Burn Care Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence of Burn Injuries Worldwide
    • 4.2.2 Increasing Adoption of Advanced Wound Dressings & Skin Grafts
    • 4.2.3 Rapid Technological Advances (NPWT, Antimicrobial Hydrogels, 3-D Bioprinting)
    • 4.2.4 Favourable Reimbursement & Government Safety Initiatives
    • 4.2.5 Rising Electrical-Vehicle & Lithium-Battery Fire Incidents
    • 4.2.6 Wild-Fire Frequency Linked to Climate Change Boosting Severe Burn Cases
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Advanced Burn-Care Products & Biologics
    • 4.3.2 Limited Reimbursement & Skilled Staff in Emerging Economies
    • 4.3.3 Stringent Regulatory Pathway for Skin-Substitute Biologics
    • 4.3.4 Raw-Material Supply Volatility (Silver, Collagen) Impacting Production
  • 4.4 Porter’s Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitutes
    • 4.4.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value in USD)

  • 5.1 By Product Type
    • 5.1.1 Advanced Dressings
    • 5.1.1.1 Foam Dressings
    • 5.1.1.2 Hydrocolloid Dressings
    • 5.1.1.3 Hydrogel Dressings
    • 5.1.1.4 Alginate Dressings
    • 5.1.1.5 Antimicrobial Silver Dressings
    • 5.1.1.6 Collagen & Silicone Dressings
    • 5.1.2 Traditional Dressings
    • 5.1.3 Biologics
    • 5.1.4 Therapy Devices
    • 5.1.5 Topical Agents
    • 5.1.6 Other Product Types
  • 5.2 By Depth of Burn
    • 5.2.1 Minor Burns
    • 5.2.2 Partial-Thickness Burns
    • 5.2.3 Full-Thickness Burns
  • 5.3 By End User
    • 5.3.1 Hospitals & Clinics
    • 5.3.2 Specialised Burn Centres
    • 5.3.3 Ambulatory Surgery Centres
    • 5.3.4 Home-Care Settings
    • 5.3.5 Military & Emergency Services
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 3M Company
    • 6.3.2 Smith & Nephew plc
    • 6.3.3 Mölnlycke Health Care AB
    • 6.3.4 ConvaTec Group plc
    • 6.3.5 Johnson & Johnson (Ethicon)
    • 6.3.6 B. Braun Melsungen AG
    • 6.3.7 Integra LifeSciences Corp.
    • 6.3.8 Medline Industries LP
    • 6.3.9 Cardinal Health Inc.
    • 6.3.10 Hollister Incorporated
    • 6.3.11 DeRoyal Industries Inc.
    • 6.3.12 Avita Medical
    • 6.3.13 PolyNovo Ltd.
    • 6.3.14 Vericel Corp.
    • 6.3.15 Organogenesis Holdings Inc.
    • 6.3.16 Stratatech (Mallinckrodt)
    • 6.3.17 Stryker Corp.
    • 6.3.18 Coloplast A/S
    • 6.3.19 Medtronic

7. Market Opportunities & Future Outlook

  • 7.1 White-Space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Burn Care Market Report Scope

As per the scope of the report, burn care products are specially formulated to heal burn wounds. Burn can cause skin cells to die and a painful burning sensation to the skin. Immediate emergency care must be provided in case of serious burns to avoid complications or even death. Burn care products help relieve discomfort and prevent scarring. The Burn Care Market is Segmented By Product Type (Advanced Dressing, Traditional Dressing, Biologics, and Other Product Types), Depth of Burn (Minor Burns, Partial Thickness Burns, Full Thickness Burns), End User (Hospitals & Clinics, Ambulatory Surgery Center, Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type Advanced Dressings Foam Dressings
Hydrocolloid Dressings
Hydrogel Dressings
Alginate Dressings
Antimicrobial Silver Dressings
Collagen & Silicone Dressings
Traditional Dressings
Biologics
Therapy Devices
Topical Agents
Other Product Types
By Depth of Burn Minor Burns
Partial-Thickness Burns
Full-Thickness Burns
By End User Hospitals & Clinics
Specialised Burn Centres
Ambulatory Surgery Centres
Home-Care Settings
Military & Emergency Services
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
By Product Type
Advanced Dressings Foam Dressings
Hydrocolloid Dressings
Hydrogel Dressings
Alginate Dressings
Antimicrobial Silver Dressings
Collagen & Silicone Dressings
Traditional Dressings
Biologics
Therapy Devices
Topical Agents
Other Product Types
By Depth of Burn
Minor Burns
Partial-Thickness Burns
Full-Thickness Burns
By End User
Hospitals & Clinics
Specialised Burn Centres
Ambulatory Surgery Centres
Home-Care Settings
Military & Emergency Services
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current size of the burn care market?

The burn care market stood at USD 2.88 billion in 2025 and is projected to reach USD 3.96 billion by 2030.

Which product category dominates revenue?

Advanced dressings accounted for 52.87% of 2024 revenue, making them the leading product segment.

Which region is growing fastest?

Asia-Pacific is forecast to expand at an 8.16% CAGR between 2025 and 2030 because of rising healthcare investment and standardized treatment protocols.

Why are ambulatory surgery centers important for future growth?

Portable NPWT devices and smart bandages enable complex wound management outside hospitals, driving a 10.19% CAGR for ambulatory centers through 2030.

How are technology advances shaping burn care?

Real-time sensors, conductive hydrogels, and 3-D bioprinting accelerate healing, reduce infections, and shorten inpatient stays, shifting budgets toward data-enabled solutions.

What challenges limit adoption of biologics?

High manufacturing costs, stringent regulatory pathways, and reimbursement scrutiny in emerging markets constrain widespread biologic uptake despite strong clinical performance.

Page last updated on: July 1, 2025

Burn Care Market Report Snapshots